Eplivanserin

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

InsomniaSleep Disorder

153 competitors in Insomnia

#DrugCompanyPhaseTrials

1

Epidiolex

Jazz Pharmaceuticals

Phase 3

22

Elavil

AstraZeneca

Phase 3

13

Neurontin

VViatris Specialty LLC

Phase 3

74

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Phase 3

35

Hetlioz

VVanda Pharmaceuticals

Phase 3

26

Gaboxadol

Lundbeck

Phase 3

87

Volinanserin

Sanofi

Phase 3

28

Prosom

AAbbott

Phase 3

49

Org 50081

Merck & Co.

Phase 3

110

Nitrazepam

Astellas

Phase 3

1Show 27 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Insomnia6 trials

Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia

Completed·Sanofi·Phase 3·NCT00253968·967 enrolled

Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia

Completed·Sanofi·Phase 3·NCT00308503·608 enrolled

Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 Year

Completed·Sanofi·Phase 3·NCT00253903·1,155 enrolled

Show 3 more trials

Single Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluation of Eplivanserin in Children With Insomnia

Completed·Sanofi·Phase 1·NCT00913614·41 enrolled

Comparison of Eplivanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties

Completed·Sanofi·Phase 3·NCT00679900·283 enrolled

Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties

Completed·Sanofi·Phase 3·NCT00805350·637 enrolled

Sleep Disorder1 trial

Efficacy and Safety of SR46349B in Patients With Sleep Disorders in Fibromyalgia

Completed·Sanofi·Phase 2·NCT00313885·205 enrolled

Details

Drug Info

Related News